Tianshui Zhongxing Bio-technology Co Ltd - Asset Resilience Ratio
Tianshui Zhongxing Bio-technology Co Ltd (002772) has an Asset Resilience Ratio of 5.37% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check Tianshui Zhongxing Bio-technology Co Ltd strategic capital allocation to assess the company's strategic physical and investment asset allocation.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2015–2024)
This chart shows how Tianshui Zhongxing Bio-technology Co Ltd's Asset Resilience Ratio has changed over time. See 002772 net asset quality score to measure how much of total assets are equity-financed.
Liquid Assets Composition Over Time
This chart breaks down Tianshui Zhongxing Bio-technology Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Tianshui Zhongxing Bio-technology Co Ltd stock valuation.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥352.09 Million | 5.37% |
| Total Liquid Assets | CN¥352.09 Million | 5.37% |
Asset Resilience Insights
- Limited Liquidity: Tianshui Zhongxing Bio-technology Co Ltd maintains only 5.37% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Tianshui Zhongxing Bio-technology Co Ltd Industry Peers by Asset Resilience Ratio
Compare Tianshui Zhongxing Bio-technology Co Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
FAP Agri Tbk PT
JK:FAPA |
Farm Products | 0.66% |
|
Far East Holdings Bhd
KLSE:5029 |
Farm Products | 0.39% |
|
Blumar
SN:BLUMAR |
Farm Products | 0.02% |
|
Jiangsu Hualv Biological Technology Co.Ltd.
SHE:300970 |
Farm Products | 0.94% |
|
Inghams Group Ltd
AU:ING |
Farm Products | 3.15% |
|
Teladan Prima Agro PT Tbk
JK:TLDN |
Farm Products | 4.09% |
|
San Miguel AG
BA:SAMI |
Farm Products | 2.46% |
|
China Shengmu Organic Milk Limited
F:7OM |
Farm Products | 1.50% |
Annual Asset Resilience Ratio for Tianshui Zhongxing Bio-technology Co Ltd (2015–2024)
The table below shows the annual Asset Resilience Ratio data for Tianshui Zhongxing Bio-technology Co Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 5.26% | CN¥325.48 Million ≈ $47.63 Million |
CN¥6.19 Billion ≈ $905.92 Million |
+0.56pp |
| 2023-12-31 | 4.69% | CN¥285.00 Million ≈ $41.70 Million |
CN¥6.07 Billion ≈ $888.78 Million |
-0.93pp |
| 2022-12-31 | 5.62% | CN¥369.51 Million ≈ $54.07 Million |
CN¥6.57 Billion ≈ $961.27 Million |
+1.60pp |
| 2021-12-31 | 4.02% | CN¥263.43 Million ≈ $38.55 Million |
CN¥6.55 Billion ≈ $958.66 Million |
-8.32pp |
| 2020-12-31 | 12.34% | CN¥688.61 Million ≈ $100.77 Million |
CN¥5.58 Billion ≈ $816.81 Million |
-0.96pp |
| 2019-12-31 | 13.29% | CN¥666.34 Million ≈ $97.51 Million |
CN¥5.01 Billion ≈ $733.55 Million |
-4.86pp |
| 2018-12-31 | 18.15% | CN¥746.00 Million ≈ $109.16 Million |
CN¥4.11 Billion ≈ $601.33 Million |
+1.75pp |
| 2017-12-31 | 16.40% | CN¥671.00 Million ≈ $98.19 Million |
CN¥4.09 Billion ≈ $598.72 Million |
-18.57pp |
| 2016-12-31 | 34.97% | CN¥1.12 Billion ≈ $164.48 Million |
CN¥3.21 Billion ≈ $470.40 Million |
+18.27pp |
| 2015-12-31 | 16.70% | CN¥281.00 Million ≈ $41.12 Million |
CN¥1.68 Billion ≈ $246.24 Million |
-- |
About Tianshui Zhongxing Bio-technology Co Ltd
Tianshui Zhongxing Bio-technology Co.,Ltd., together with its subsidiaries, engages in the research and development, production, and sale of edible fungi in China and internationally. It offers flammulina velutipe mushrooms under the Xihuang brand; agaricus bisporus mushrooms under the Zhongxing brand; and cordyceps sinensis mushrooms, as well as packaging boxes for its products. The company also… Read more